203 related articles for article (PubMed ID: 26235097)
1. Chemokine (C-X-C motif) receptor 3-positive B cells link interleukin-17 inflammation to protumorigenic macrophage polarization in human hepatocellular carcinoma.
Liu RX; Wei Y; Zeng QH; Chan KW; Xiao X; Zhao XY; Chen MM; Ouyang FZ; Chen DP; Zheng L; Lao XM; Kuang DM
Hepatology; 2015 Dec; 62(6):1779-90. PubMed ID: 26235097
[TBL] [Abstract][Full Text] [Related]
2. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma and CXCR3 chemokines: a narrative review.
Elia G; Fallahi P
Clin Ter; 2017; 168(1):e37-e41. PubMed ID: 28240761
[TBL] [Abstract][Full Text] [Related]
4. Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC).
Yan Y; Zheng L; Du Q; Yazdani H; Dong K; Guo Y; Geller DA
Cancer Lett; 2021 May; 506():95-106. PubMed ID: 33689775
[TBL] [Abstract][Full Text] [Related]
5. Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma.
Liu YQ; Poon RT; Hughes J; Li QY; Yu WC; Fan ST
World J Gastroenterol; 2005 Jan; 11(2):164-70. PubMed ID: 15633209
[TBL] [Abstract][Full Text] [Related]
6. Polarization of Tissue-Resident TFH-Like Cells in Human Hepatoma Bridges Innate Monocyte Inflammation and M2b Macrophage Polarization.
Chen MM; Xiao X; Lao XM; Wei Y; Liu RX; Zeng QH; Wang JC; Ouyang FZ; Chen DP; Chan KW; Shi DC; Zheng L; Kuang DM
Cancer Discov; 2016 Oct; 6(10):1182-1195. PubMed ID: 27531854
[TBL] [Abstract][Full Text] [Related]
7. Post-transplant endothelial progenitor cell mobilization via CXCL10/CXCR3 signaling promotes liver tumor growth.
Ling CC; Ng KT; Shao Y; Geng W; Xiao JW; Liu H; Li CX; Liu XB; Ma YY; Yeung WH; Qi X; Yu J; Wong N; Zhai Y; Chan SC; Poon RT; Lo CM; Man K
J Hepatol; 2014 Jan; 60(1):103-9. PubMed ID: 23994383
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
[TBL] [Abstract][Full Text] [Related]
9. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma.
Kuang DM; Zhao Q; Wu Y; Peng C; Wang J; Xu Z; Yin XY; Zheng L
J Hepatol; 2011 May; 54(5):948-55. PubMed ID: 21145847
[TBL] [Abstract][Full Text] [Related]
10. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.
Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N
Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550
[TBL] [Abstract][Full Text] [Related]
11. CXCL10/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation.
Li CX; Ling CC; Shao Y; Xu A; Li XC; Ng KT; Liu XB; Ma YY; Qi X; Liu H; Liu J; Yeung OW; Yang XX; Liu QS; Lam YF; Zhai Y; Lo CM; Man K
J Hepatol; 2016 Nov; 65(5):944-952. PubMed ID: 27245433
[TBL] [Abstract][Full Text] [Related]
12. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
13. Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells.
Kuang DM; Peng C; Zhao Q; Wu Y; Chen MS; Zheng L
Hepatology; 2010 Jan; 51(1):154-64. PubMed ID: 19902483
[TBL] [Abstract][Full Text] [Related]
14. [Expression of CXCR3 in hepatocellular carcinoma].
Shi M; Guo RP; Zhang CQ; Zhong C; Lin XJ; Li JQ
Ai Zheng; 2006 Oct; 25(10):1232-7. PubMed ID: 17059766
[TBL] [Abstract][Full Text] [Related]
15. B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury.
Faggioli F; Palagano E; Di Tommaso L; Donadon M; Marrella V; Recordati C; Mantero S; Villa A; Vezzoni P; Cassani B
Hepatology; 2018 May; 67(5):1970-1985. PubMed ID: 29105104
[TBL] [Abstract][Full Text] [Related]
16. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
17. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice.
Santodomingo-Garzon T; Han J; Le T; Yang Y; Swain MG
Hepatology; 2009 Apr; 49(4):1267-76. PubMed ID: 19140218
[TBL] [Abstract][Full Text] [Related]
18. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells.
Sprinzl MF; Reisinger F; Puschnik A; Ringelhan M; Ackermann K; Hartmann D; Schiemann M; Weinmann A; Galle PR; Schuchmann M; Friess H; Otto G; Heikenwalder M; Protzer U
Hepatology; 2013 Jun; 57(6):2358-68. PubMed ID: 23424039
[TBL] [Abstract][Full Text] [Related]
20. Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment.
Petty AJ; Li A; Wang X; Dai R; Heyman B; Hsu D; Huang X; Yang Y
J Clin Invest; 2019 Dec; 129(12):5151-5162. PubMed ID: 31638600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
